Vivo Capital’s Timber Pharmaceuticals, Inc. TMBR Stock Holding History

Vivo Capital’s Portfolio TMBR Stock Details TMBR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-529	Closed	-$189K	–	41
2019 Q2	$189K	Sell	529 -546	-51%	-$426K	0.02%	45
2019 Q1	$1.42M	Hold	1,075	–	–	0.14%	45
2018 Q4	$1.74M	Hold	1,075	–	–	0.22%	37
2018 Q3	$3.06M	Hold	1,075	–	–	0.31%	38
2018 Q2	$3.56M	Hold	1,075	–	–	0.46%	32
2018 Q1	$3.73M	Buy	1,075 +155	+17%	+$460K	0.53%	28
2017 Q4	$1.52M	Sell	920 -20	-2%	-$54.5K	0.33%	28
2017 Q3	$4.03M	Hold	940	–	–	0.81%	22
2017 Q2	$6.75M	Buy	940 +86	+10%	+$749K	1.7%	13
2017 Q1	$6.47M	Hold	854	–	–	1.9%	10
2016 Q4	$4.79M	Buy	+854	New	+$4.37M	1.58%	15

Other funds holding TMBR

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Vivo Capital's TMBR Position: Q3 2019 in Review

Vivo Capital sold out of Timber Pharmaceuticals, Inc. (TMBR) in Q3 2019, closing a stake of 529 shares — an estimated $189K sold.

Vivo Capital first reported a position in TMBR in Q4 2016 and held it in 11 quarters. The position peaked at $6.75M in Q2 2017. 12 funds tracked by Wall St. Rank hold TMBR as of Q3 2019.

Vivo Capital reported no remaining Timber Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
Vivo Capital sold 529 Timber Pharmaceuticals, Inc. shares in Q3 2019, an estimated $189K.
Vivo Capital first reported a position in Timber Pharmaceuticals, Inc. in Q4 2016 and held it in 11 quarters.
Vivo Capital's Timber Pharmaceuticals, Inc. position peaked at $6.75M in Q2 2017.
12 funds tracked by Wall St. Rank held Timber Pharmaceuticals, Inc. as of Q3 2019.

Based on Vivo Capital's 13F filing for Q3 2019, filed 13 Nov 2019.